Allegro Ophthalmics Begins Phase 2 Clinical Study of Luminate® for Non-Proliferative Diabetic Retinopathy

by Business Wire • 2015/05/04 • 0 Comments

DENVER--(BUSINESS WIRE)--Allegro Ophthalmics announced that it has begun enrolling patients in a Phase 2 clinical trial that will evaluate Luminate® in inducing PVD in patients with non-proliferative diabetic retinopathy.

← Ultra-widefield imaging may assess vitreous haze in uveitis patients

VIDEO: Study shows eye banks able to prepare and transport fully-peeled DMEK tissue →

Post navigation